Parkedale

Parkedale Pharmaceuticals was a specialty pharmaceutical company and manufacturing entity primarily known for its production of vaccines and sterile injectable products. Originally a division of Parke-Davis (Warner-Lambert), the company became a subsidiary of King Pharmaceuticals in 1998. Its primary operations were centered in Rochester, Michigan, where it manufactured the influenza vaccine Fluogen and various antivenins. Following the acquisition of King Pharmaceuticals by Pfizer in 2011, Parkedale's operations were integrated into Pfizer's global manufacturing network, and the specific Parkedale brand was largely retired.